The Kelowna Diabetes Program: Bridging the gap between testing guidelines and reality

Canadian Journal of Diabetes

Volumn 32, Issue 2, 2008, Pages 107-113

  Innes, Duncan ^a   Cameron, David ^a   Farquhar, Andrew ^b   Tildesley, Hugh ^c   Green, Larry ^a   Fraser, Tyler ^d  

^a Valley Medical Laboratories   (Canada)

^b Mission View Medical   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

Chronic disease management; Clinical practice guidelines; Direct reporting to patients; Self management of diabetes; Supported diabetes care

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CANADA; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; HEALTH PROGRAM; HUMAN; KELOWNA DIABETES PROGRAM; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE;

EID: 45849083810     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(08)22007-1     Document Type: Article

References (22)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S152.
2. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
3. Koro CE, Bowlin SJ, Bourgeois N, et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20.
4. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
5. A snapshot of diabetes care in British Columbia 2003/2004. British Columbia Ministry of Health web site. Available at: http://www.healthservices. gov.bc.ca/cdm/research/diabetes_snapshot_2004.pdf Accessed May 15, 2008.
6. Harris SB, Ekoé J-M, Zdanowicz Y, et al. Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes In Canada Evaluation study). Diabetes Res Clin Pract. 2005;70:90-97.
7. Klein R, Klein BE, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 1988;260:2864-2871.
8. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-2569.
9. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
10. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316:823-828.
11. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381-389.
12. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
13. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
14. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1-9.
15. Piatt GA, Zgibor JC. Novel approaches to diabetes care: a population perspective. Curr Opin Endocrinol Diabetes Obes. 2007;14:158-165.
16. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004;22:123-128.
17. Heisler M, Piette JD, Spencer M, et al. The relationship between knowledge of recent HbA1C values and diabetes care understanding and self-management. Diabetes Care. 2005;28:816-822.
18. Deichmann RE, Castello E, Horswell R, et al. Improvements in diabetic care as measured by HbA1c after a physician education project. Diabetes Care. 1999;22:1612-1616.
19. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007;369:750-756.
20. Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006;30:371-377.
21. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med. 2007;356:213-215.
22. Rachmani R, Levi Z, Slavachevski I, et al. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with type 2 diabetes mellitus - a randomized prospective study. Diabet Med. 2002;19:385-392.